Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66.4M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
30.3M
-
Shares change
-
-435K
-
Total reported value, excl. options
-
$885M
-
Value change
-
-$10.3M
-
Number of buys
-
44
-
Number of sells
-
-37
-
Price
-
$29.17
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2018
91 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q3 2018.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.3M shares
of 66.4M outstanding shares and own 45.69% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.91M shares), MPM ASSET MANAGEMENT LLC (3.07M shares), JANUS HENDERSON GROUP PLC (3.05M shares), TRV GP, LLC (2.98M shares), BAKER BROS. ADVISORS LP (2.71M shares), RA CAPITAL MANAGEMENT, LLC (1.95M shares), FMR LLC (1.62M shares), BlackRock Inc. (1.14M shares), Vanguard Group Inc (1.05M shares), and ORBIMED ADVISORS LLC (1.04M shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.